发明人黄志刚,陈志强,何建平. "Method for the Synthesis of Axitinib Impurity 37" [P]. 中国发明专利, 专利号 CN 112684616 B, 授权公告日 2016-11-17.
发明人徐明华,刘建华,郑宇鹏. "A Process for Preparing High-Purity Axitinib Impurity 37" [P]. 中国发明专利, 专利号 CN 109493877 A, 授权公告日 2015-06-10.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质37 in Pharmaceutical Formulations". J. Nat. Prod., 2024, 1541, 5377-5383.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质37 as an Impurity". J. Sep. Sci., 2011, 254, 6841-6866.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 37 Using HRMS and NMR". J. Agric. Food Chem., 2018, 728, (9), 7191-7217.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 阿昔替尼杂质37 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2013, 750, 5760-5780.